Sir James Black | |
---|---|
Born | James Whyte Black 14 June 1924 Uddingston, Lanarkshire, Scotland |
Died | 22 March 2010 London, England | (aged 85)
Nationality | British |
Citizenship | United Kingdom |
Alma mater | University of St Andrews |
Known for | work towards the use of propranolol and cimetidine |
Awards |
|
Scientific career | |
Fields | Pharmacology |
Institutions | |
Website | www |
Sir James Whyte Black (14 June 1924 – 22 March 2010[2]) was a Scottish physician and pharmacologist. Together with Gertrude B. Elion and George H. Hitchings, he shared the Nobel Prize for Medicine in 1988 for pioneering strategies for rational drug-design, which, in his case, led to the development of propranolol and cimetidine.[3][4] Black established a Veterinary Physiology department at the University of Glasgow, where he became interested in the effects of adrenaline on the human heart. He went to work for ICI Pharmaceuticals in 1958 and, while there, developed propranolol, a beta blocker used for the treatment of heart disease.[5] Black was also responsible for the development of cimetidine, an H2 receptor antagonist, a drug used to treat stomach ulcers.
frs
was invoked but never defined (see the help page).ObitSTV
was invoked but never defined (see the help page).nobel
was invoked but never defined (see the help page).